Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

XLOXLO

2 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in XILIO THERAPEUTICS INC

No. Susquehanna International Group exited its XLO (Xilio Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 49,093 shares worth $46,884. Susquehanna International Group first reported XLO in Q4 2024 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$46,884

Total Shares Change

-49,093

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$10.14
0
2024-Q4
New
49,093
—
$46,8840.0%$13.37
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used